Monday, July 28, 2025

MAHINDRA LAUNCHES XUV 3XO 'REVX' SERIES STARTING AT Rs.8.94 LAKHS - FEATURE PACKED,STYLE-FORWARD AND REVVED FOR PERFORMANCE.

 Mahindra & Mahindra  Ltd.,India's leading SUV manufacturer,unveiled the exciting new XUV 3XO Series, starting at an attractive price of Rs.8.94 lakhs with striking new exteriors with new body colored grille,black alloy wheels,dual tone roof and distinctive badging. Also with premium interiors offering exceptional value for sutomers in C-SUV segment under 10 lakh with leatherette seats and sun roof.The XUV 3XO recently achieved an impressive milestone of over 1 lakh sales under a year, making it Mahindra's fastest SUV to reach the milestone.The REVX sries wll further enhance the XUV 3XO portfolio with a compelling value offering of premium features,distinctive styling and best in segment performance,resonating with customer aspirations.


commenting on the launch,Mr.Baneshwar Banerjee,Vice President and National Head, -sales,Automative sector,Mahindra & Mahindra Ltd., said," The XUV 3XO has emerged as a game changer in the compact SUV segment & with the launch of the REVX series,we are elevating this success by offering bold styling,premium features and segment leading performance at competetive price points enhancing the overall value proposition.These new variants are designed to cater the growing demand for feature -rich, value driven SUV's that align with evolving customer aspirations."


About Mahindra & Mahindra ltd.:  The company was founded in 1945, and the Group is one of the most admired multinational federation of companies with 2,60,000 employees in over 100 countries.It has a strong presence in renewable energy,agriculture,logistics,hospitality and real estate.

Wednesday, July 23, 2025

BRIGADE HOTEL VENTURES LIMITED- INITIAL PUBLIC OFFERING- PRICE BAND OF Rs.85 to Rs.90/- PER EQUITY SHARE OF Rs.10 EACH.

BRIGADE HOTEL VENTURES LTD., 100% Subsidiary of Brigade Enterprises Limited is coming out with an Initial Public Offering amounting to Rs.759.60 crores. Bid/issue opening date: Thursday,July 24,2025, Bid Issue / Closing Date; Monday,July,28,2025. Anchor date; The Anchor Investor Bidding date is one working day prior to Bid /Issue Opening date,being Wednesday,July,23,2025.Brigade Hotel Ventures Ltd., IPO has reserved 75% of the issue for qualified institutional buyers (QIB), and 15 % for non institutional investors (NII).For retail investors,the company has reserved 10% of the issue.


Bids can be made for a minimum of 166 Equity shares and multiples of 166 Equity shares  thereafter. A discount of Rs.3/per Equity share is being offered to eligible Employees bidding in the Employee Reservation  portion. IPO Objective: According to RHP,the Company intends to use the net proceeds to repay the borrowings,pay consideration for buying undivided shares of land from its promoter Brigade Enterprises ltd.,,Pursue inorganic growth through unidentified acquisitions, and fund other strategic initiatives  & general corporate purposes.

As of march 31,2025,the company ranks as the second largest owner of  chain -affiliated hotels & Hotel rooms in South India operating in Kerala,Karnataka,Andhra pradesh,Tamilnadu,Telengana & in GIFT City in Gujarat. with 1604 keys.The Company reported revenue of Rs.470.68 crores  in 2025  against Rs.404.85 crores in 2024.the companyy reported profit of Rs.23.66 crores in 2025 against Rs.31.14 crores in 2024. In order to promote its hotels,the Company has signed contracts with international brands like Marriott,Accor,& Inter continental Hotels group.

The Company's shares will be listed in both BSE &NSE on July,31,2025.

Thursday, July 10, 2025

OMRON & TRICOG HEALTH LAUNCH KEEBOHEALTH TO COMBAT INDIA'S CARDIAC CRISIS & DRIVE "GOING FOR ZERO" VISION.

                                                        
                                              
                                                                 

OMRON  Healthcare,a global leader in innovative Home health monitoring solutions,has expanded its collaboration with Tricog Health,an AI - driven cardiac care company,to launch KeeboHealth  -an advanced connected health platform designed to transform remote cardiac care and accelerate progress towards OMRON's ambitious "Going For Zero" -a world with zero cardio vascular events.    KeeboHealth is a ground breaking digital health eco system that leverages state-of-the-art AI technology,real-time data analytics,and home based monitoring to empower health care providers & patients in managing heart conditions more effectively.The data flows in real-time to Tricog's AI engine,which continuously monitors heart health,flags early warning signs,and instantly alert medical teams when intervention is needed.This pro active system helps detect   heart issues before a patient's condition deteriorates,significantly  reducing the need for hospitalization.  The platform integrates seamlessly with OMRON's range of connected devices-including home ECG monitors,blood pressure monitors and weighing scales-enabling continuous & personalized care.


Ms..Ayumu Okada,Director,President & CEO,OMRON Healthcare Co.Ltd. said," For more than 40 years since we first launched blood pressure monitor in India in the 1980's,we have been working to solve the health challenges faced by people living in  India. KeeboHealth  is a new solution that combines our innovative devices enabling early detection of deteriorating condition & appropriate intervention for patients  & also expected to improve the work efficiency of medical professionals".    



Mr.Hokuta Kaya,Deputy Consul General of Japan in Bengaluru,said," "This ground-breaking partnership between Omron Healthcare and Tricog Health exemplifies the power of combining Japanese  technological excellence with Indian Ingenuity."

Dr. Charit Bhograj,CEO & Founder,Tricog Health commented"  KeeboHealth is more than technology-it is hope for millions living with heart failure.Together,we are moving closer to a world where "zero cardio vascular events"is not just an aspiration but a reality". Further,Dr. Charith Bhograj  said,around 20 millions lives are lost globally due to cardiac arrests. To a question by our Editor,  regarding talks about covid Vaccines may be one of the reasons for the cardiac problems,Dr.Charit Bhograj said "Vaccines donot cause any heart problems ".